Yoshida K - Search Results

1

Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.

Mimoto R, Imawari Y, Hirooka S, Takeyama H, Yoshida K. Mimoto R, et al. Among authors: yoshida k. Oncogene. 2017 Mar 30;36(13):1862-1872. doi: 10.1038/onc.2016.349. Epub 2016 Oct 10. Oncogene. 2017. PMID: 27721402

2

TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress.

Nihira K, Taira N, Miki Y, Yoshida K. Nihira K, et al. Among authors: yoshida k. Oncogene. 2008 Dec 11;27(58):7285-95. doi: 10.1038/onc.2008.334. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794806

3

ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin.

Yoshida K, Ozaki T, Furuya K, Nakanishi M, Kikuchi H, Yamamoto H, Ono S, Koda T, Omura K, Nakagawara A. Yoshida K, et al. Oncogene. 2008 Feb 14;27(8):1183-8. doi: 10.1038/sj.onc.1210722. Epub 2007 Aug 13. Oncogene. 2008. PMID: 17700524

4

NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.

Kikuchi H, Ozaki T, Furuya K, Hanamoto T, Nakanishi M, Yamamoto H, Yoshida K, Todo S, Nakagawara A. Kikuchi H, et al. Among authors: yoshida k. Oncogene. 2006 Dec 7;25(58):7608-17. doi: 10.1038/sj.onc.1209748. Epub 2006 Sep 4. Oncogene. 2006. PMID: 16953234

5

Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage.

Dashzeveg N, Taira N, Lu ZG, Kimura J, Yoshida K. Dashzeveg N, et al. Among authors: yoshida k. Cell Death Dis. 2014 May 8;5(5):e1221. doi: 10.1038/cddis.2014.176. Cell Death Dis. 2014. PMID: 24810057 Free PMC article.

6

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.

Ohmine K, Ota J, Ueda M, Ueno S, Yoshida K, Yamashita Y, Kirito K, Imagawa S, Nakamura Y, Saito K, Akutsu M, Mitani K, Kano Y, Komatsu N, Ozawa K, Mano H. Ohmine K, et al. Among authors: yoshida k. Oncogene. 2001 Dec 13;20(57):8249-57. doi: 10.1038/sj.onc.1205029. Oncogene. 2001. PMID: 11781839

7

Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.

Kawami H, Yoshida K, Ohsaki A, Kuroi K, Nishiyama M, Toge T. Kawami H, et al. Among authors: yoshida k. Anticancer Res. 1993 Nov-Dec;13(6A):2319-23. Anticancer Res. 1993. PMID: 8297152

8

The expression and biological activity of IL-2 receptor on a human pancreas cancer cell line.

Kawami H, Yoshida K, Yamaguchi Y, Saeki T, Toge T. Kawami H, et al. Among authors: yoshida k. Biotherapy. 1993;6(1):33-9. doi: 10.1007/BF01877384. Biotherapy. 1993. PMID: 8507543

9

Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.

Taira N, Yoshida K. Taira N, et al. Among authors: yoshida k. Histol Histopathol. 2012 Apr;27(4):437-43. doi: 10.14670/HH-27.437. Histol Histopathol. 2012. PMID: 22374721 Review.

10

Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.

Nihira K, Ando Y, Yamaguchi T, Kagami Y, Miki Y, Yoshida K. Nihira K, et al. Among authors: yoshida k. Cell Death Differ. 2010 Apr;17(4):689-98. doi: 10.1038/cdd.2009.174. Epub 2009 Nov 13. Cell Death Differ. 2010. PMID: 19911008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,879 results

Search Page

Filters